Japan suspends use of anti-flu drug Tamiflu for teens

TOKYO, Japan - The anti-flu drug Tamiflu, wrapped in packages sold in Japan. (File photo) The drug, manufactured by Roche Holding AG of Switzerland, is imported and sold in Japan by Chugai Pharmaceutical Co. The Japanese health ministry announced March 21 that the government has recommended against the use of the anti-flu drug Tamiflu among teenagers. (Kyodo)

Sample
PDF Preview

Product Code
ILEA000035500

Registered date
2007/3/21 00:00:00

Credit
Kyodo / Kyodo News Images

Media source

Media size
1763 × 1175 pixel

Resolution
72 dpi

Deployment size
351.47(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Face of woman from prehistoric Japan

Photo taken in March 2018 at the National Museum of Nature and Science in Tokyo shows a women's skull from Japan's prehistoric Jomon period, unearthed in Hokkaido, and a model face reproduced with the use of DNA technology. (Kyodo) ==Kyodo

Purported "STAP cells" likely came from embryonic stem cells

TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21. (Kyodo)

Obokata agrees to retract primary STAP cell paper

TOKYO, Japan - In this file photo taken in Kobe in western Japan on Jan. 28, 2014, Japanese scientist Haruko Obokata briefs reporters on the production of so-called STAP cells capable of developing into any type of tissue. The government-backed Riken institute said on June 4, 2014, that Obokata has agreed to retract a key paper claiming STAP cell production and deliver the agreed document to co-authors of the paper.

STAP cell research paper questioned

TOKYO, Japan - File photo taken in January 2014 in Kobe, Hyogo Prefecture, shows Haruko Obokata (L), a scientist at the Riken Center for Developmental Biology, and University of Yamanashi professor Teruhiko Wakayama, at a press conference on "stimulus-triggered acquisition of pluripotency," or STAP, a method of generating pluripotent cells. Wakayama said March 10, 2014, he has told his co-authors including Obokata that their research paper on STAP cells should be retracted, citing the lack of credibility of some data used in the research.

Resin spray over nuclear plant

TOKYO, Japan - File photo shows resin which workers began test-spraying on April 1, 2011, at a nuclear power plant crippled by the March 11 earthquake and tsunami in Fukushima Prefecture to prevent radioactive particles from being dispersed. Tokyo-based Kurita Water Industries Ltd. developed this water-soluble resin, which has coating effects. The company said the resin was originally developed for use in land reclamation and development work to prevent sand from being dispersed, so its efficiency in solidifying radioactive materials with soil is uncertain. The resin is painted green to make it easy for workers to see areas that have been already sprayed. (Kyodo)

Pollen dispersed from cedar

TOKYO, Japan - File photo taken in March 2005 shows pollen dispersed from a cedar in Sagamihara, Kanagawa Prefecture. (Kyodo)

Longest operation eyed at Japan nuclear plant

SENDAI, Japan - This October 2008 file photo shows the No. 3 reactor of the Fukushima No. 2 nuclear plant in Fukushima Prefecture. The operator of the plant, Tokyo Electric Power Co., is planning to commence by the end of 2011 continuous operation of the reactor for up to 16 months, which would be the longest period it has operated a nuclear reactor without a checkup. (Kyodo)

JR East's ambition: electricity generation by train riders

TOKYO, Japan - East Japan Railway Co. will be testing piezoelectric devices (photo) at Tokyo Station on Jan. 19 to produce electricity through vibration power as train riders walk through railway ticket gates. JR East engineers estimate the power generated by one person walking past a piezoelectric floor device laid at a gate will be enough to light up a 100-watt electric bulb by 0.01 second, or 80 minutes of lighting per day. Piezoelectric devices in speakers produce vibration, and sound, when activated by electric current. Using the reverse principle, JR East engineers have been testing the use of vibration on pieozoelectric devices to produce electricity. The tests at Tokyo Station's Yaesu North entrance will run until early March. The amount of electricity produced will be shown on a monitor near the gate. (Kyodo)

Japan suspends use of anti-flu drug Tamiflu for teens

TOKYO, Japan - Tatsuo Kurokawa (2nd L), the health ministry official in charge of pharmaceutical matters, announces at a predawn news conference in Tokyo on March 21 that the government has recommended against the use of the anti-flu drug Tamiflu among teenagers. After taking Tamiflu, two 12-year-old boys apparently jumped off the second floor of their houses and broke their legs in February and March. In February, a 14-year-old boy fell to his death at his condominium in Miyagi after apparently taking the drug while a 14-year-old girl died in similar circumstances in Aichi. (Kyodo)

Tokyo Electric also had reactor troubles

TOKYO, Japan - Tokyo Electric Power Co.'s No. 2 Fukushima nulear power plant in Fukushima Prefecture. (File photo, taken in September 2002). Tokyo Electric says March 20 that it has unreported problems with reactor control rods at its Fukushima No. 2 nuclear power plant in Fukushima in June 1993 and at the Kashiwazaki-Kariwa plant in April 2000 during regular checkups. Three other regional electric power companies have also reported similar nuclear power plant control problems and prompted a government investigation. (Kyodo)